3395Saint Marc Holdings

2492Infomart

6912KIKUSUI HOLDINGS

7810Crossfor

7637Hakudo

2154Open Up Group

9377AGP

1430First-corporation

3294e'grand

8938GLOME Holdings

8051YAMAZEN

3097The Monogatari Corporation

4563AnGes

7092Fast Fitness Japan

8737Akatsuki Corp

9787AEON DELIGHT

2586FRUTA FRUTA

6625JALCO Holdings

2311EPCO

9602TOHO

9531TOKYO GAS

2999Home Position

9857EIWA

8179Royal Holdings

3753FLIGHT SOLUTIONS

3998SuRaLa Net

3916Digital Information Technologies

4760ALPHA

4304Estore

6073ASANTE

2984Yamaichi Uniheim Real Estate

3277Sansei Landic

7368HYOJITO

9960TOTECH

3113UNIVA Oak Holdings

4286CL Holdings

3457&Do Holdings

2767TSUBURAYA FIELDS HOLDINGS

3173Cominix

9622SPACE

8119SANYEI CORPORATION

3968Segue Group

3293AZUMA HOUSE

7343Broad-Minded

4326INTAGE HOLDINGS

4572Carna Biosciences

4379Photosynth

6835Allied Telesis HD

6656inspec

9904Verite

3392DELICA FOODS HOLDINGS

2404TETSUJIN Holdings

4171Global Information

7112CUBE

3032GOLF DO

7593VT HOLDINGS

7213LECIP HOLDINGS

4381BPLATS

6157NS TOOL

2702Mcdonald's Holdings(Japan)

6890Ferrotec Holdings

3652Digital Media Professionals

2488JTP

4310Dream Incubator

2384SBS Holdings

7640TOP CULTURE

6867LEADER ELECTRONICS

9997BELLUNA

7376BCC

8918LAND

6879IMAGICA GROUP

6547GREENS

6676MELCO HOLDINGS

4293SEPTENI HOLDINGS

3196HOTLAND

4745Tokyo Individualized Educational Institute

2173HAKUTEN

1904TAISEI ONCHO

5805SWCC

7699OMNI-PLUS SYSTEM

8920TOSHO

3918PCI Holdings

6640I-PEX

4284SOLXYZ

9621CTI Engineering

3950THE PACK

2735WATTS

5933ALINCO

9517eREX

4891TMS

2321Softfront

3435SANKO TECHNO

3965Capital Asset Planning

7771Nihon Seimitsu

4012AXIS

5011NICHIREKI GROUP

4674CRESCO

6750ELECOM

6837KYOSHA

6840AKIBA Holdings

6460SEGA SAMMY HOLDINGS

3030HUB

6294OKADA AIYON

3387create restaurants holdings

5834SBI Leasing Services

3401Teijin

9740CENTRAL SECURITY PATROLS

3490Azplanning

3837Ad-Sol Nissin

3395Saint Marc Holdings

2492Infomart

6912KIKUSUI HOLDINGS

7810Crossfor

7637Hakudo

2154Open Up Group

9377AGP

1430First-corporation

3294e'grand

8938GLOME Holdings

8051YAMAZEN

3097The Monogatari Corporation

4563AnGes

7092Fast Fitness Japan

8737Akatsuki Corp

9787AEON DELIGHT

2586FRUTA FRUTA

6625JALCO Holdings

2311EPCO

9602TOHO

9531TOKYO GAS

2999Home Position

9857EIWA

8179Royal Holdings

3753FLIGHT SOLUTIONS

3998SuRaLa Net

3916Digital Information Technologies

4760ALPHA

4304Estore

6073ASANTE

2984Yamaichi Uniheim Real Estate

3277Sansei Landic

7368HYOJITO

9960TOTECH

3113UNIVA Oak Holdings

4286CL Holdings

3457&Do Holdings

2767TSUBURAYA FIELDS HOLDINGS

3173Cominix

9622SPACE

8119SANYEI CORPORATION

3968Segue Group

3293AZUMA HOUSE

7343Broad-Minded

4326INTAGE HOLDINGS

4572Carna Biosciences

4379Photosynth

6835Allied Telesis HD

6656inspec

9904Verite

3392DELICA FOODS HOLDINGS

2404TETSUJIN Holdings

4171Global Information

7112CUBE

3032GOLF DO

7593VT HOLDINGS

7213LECIP HOLDINGS

4381BPLATS

6157NS TOOL

2702Mcdonald's Holdings(Japan)

6890Ferrotec Holdings

3652Digital Media Professionals

2488JTP

4310Dream Incubator

2384SBS Holdings

7640TOP CULTURE

6867LEADER ELECTRONICS

9997BELLUNA

7376BCC

8918LAND

6879IMAGICA GROUP

6547GREENS

6676MELCO HOLDINGS

4293SEPTENI HOLDINGS

3196HOTLAND

4745Tokyo Individualized Educational Institute

2173HAKUTEN

1904TAISEI ONCHO

5805SWCC

7699OMNI-PLUS SYSTEM

8920TOSHO

3918PCI Holdings

6640I-PEX

4284SOLXYZ

9621CTI Engineering

3950THE PACK

2735WATTS

5933ALINCO

9517eREX

4891TMS

2321Softfront

3435SANKO TECHNO

3965Capital Asset Planning

7771Nihon Seimitsu

4012AXIS

5011NICHIREKI GROUP

4674CRESCO

6750ELECOM

6837KYOSHA

6840AKIBA Holdings

6460SEGA SAMMY HOLDINGS

3030HUB

6294OKADA AIYON

3387create restaurants holdings

5834SBI Leasing Services

3401Teijin

9740CENTRAL SECURITY PATROLS

3490Azplanning

3837Ad-Sol Nissin

What's New
New Analyst Reports
Information

What's New

  • 12/05/2024NEW
  • MELCO HOLDINGS(6676)
  • [Delayed](Add)Absorption-type Merger of Subsidiary(Simplified & Short-form Merger),Change of Company Trade Name,Amendment to Articles of Incorporation
  • Mcdonald's Holdings(Japan)(2702)
  • Monthly IR News
  • CUBE(7112)
  • [Delayed] Financial results briefing materials for the Third Quarter of the Fiscal Year Ending December 31, 2024
  • [Delayed] [FY12/24] Preliminary Monthly Sales Report of Directly Managed Stores for November 2024
  • 12/04/2024NEW
  • AnGes(4563)
  • AV-001 Receives Positive Recommendation of moving to the Cohort with highest dose from the IDSMB
  • IMAGICA GROUP(6879)
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
  • Infomart(2492)
  • Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/24 [Report Update]
  • AEON DELIGHT(9787)
  • Analyst Report(Shared Research) : Achieved the use of renewable energy equivalents at all offices
  • 12/03/2024NEW
  • TOP CULTURE(7640)
  • FY10/2025 Preliminary sales figures (November)
  • 12/02/2024
  • SEGA SAMMY HOLDINGS(6460)
  • Notice regarding Issuance of Integrated Report 2024
  • NS TOOL(6157)
  • Notice Regarding Completion of Payment for the Disposal of Treasury Stock as Restricted Stock Compensation
  • MELCO HOLDINGS(6676)
  • Notice Concerning Status of Purchase of Treasury Shares
  • [Delayed]Notice of the Extraordinary General Meeting of Shareholders
  • 11/29/2024
  • HUB(3030)
  • Briefing Material for the Financial Results in Q2 FY2/25
  • eREX(9517)
  • Announcement of the Issuance of erex Group's Integrated Report "INTEGRATED REPORT 2024"(English version)
  • 11/28/2024
  • e'grand(3294)
  • Financial Results for Q2 FY3/25 (Semi-annual Period)
  • PCI Holdings(3918)
  • NOTICE OF THE 20TH ORDINARY GENERAL MEETING OF SHAREHOLDERS
  • 11/27/2024
  • EPCO(2311)
  • [Delayed]FY2024 Q3 Financial Results¡ÊJanuary-September¡Ë
  • Sansei Landic(3277)
  • [Delayed]Supplementary Materials for Consolidated Financial Results for 3Q of FY12/24
  • 11/26/2024
  • MELCO HOLDINGS(6676)
  • [Delayed]Notice Concerning Dividends of Surplus (Interim Dividends)
  • NS TOOL(6157)
  • Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
  • 11/25/2024
  • IMAGICA GROUP(6879)
  • [Delayed]Financial Results Presentation Second Quarter of the fiscal year ending March 31, 2025(2Q FY2024)
  • SuRaLa Net(3998)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • [IR STREET REPORT]: Company focused on community service, seeking to improve the academic performance of all children mainly through e-learning business that harnesses AI
  • EPCO(2311)
  • Analyst Report(Shared Research) : Monthly results for October 2024
  • OKADA AIYON(6294)
  • Revision of Full-year Business Forecasts
  • 11/22/2024
  • EPCO(2311)
  • Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/24 [Report Update]
  • WATTS(2735)
  • [IR STREET REPORT]: Significant profit increase supported by effective cost control measures. Aim to achieve an ROE of 8% in the current fiscal year.
  • Open Up Group(2154)
  • Notice of Monthly Disclosure of Utilization Rates and Number of Domestic Engineers as of the end of October 2024
  • ALINCO(5933)
  • [Delayed]Results of Operations for Second Quarter of the Fiscal Year Ending March 20, 2025
  • 11/21/2024
  • Dream Incubator(4310)
  • Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
  • 11/20/2024
  • SWCC(5805)
  • Notice Regarding Acquisition of Credit Rating
  • The Monogatari Corporation(3097)
  • Reference material for briefing the financial results for the first quarter of the FY ending June 2025
  • &Do Holdings(3457)
  • Shared Research Inc. short report on earnings results for the First Quarter of FY06/2025 has been issued
  • 11/19/2024
  • AnGes(4563)
  • American Heart association - Scientific Session November 18th 2024 -Collategene (HGF gene therapy product)
  • Saint Marc Holdings(3395)
  • Notice of Difference between Business Forecasts and Actual Results for the Second Quarter of the Fiscal Year Ending March 31, 2025
  • Fast Fitness Japan(7092)
  • Transcript of Financial results briefing for Q2 for the Fiscal Year Ending March 31, 2025
  • YAMAZEN(8051)
  • FY3/25 Q2 (Semi-annual Period) Supplementary Materials for Financial Results
  • 11/18/2024
  • TOTECH(9960)
  • [Delayed]Consolidated Financial Results for the Six Months Ended September 30, 2024 [Japanese GAAP]
  • VT HOLDINGS(7593)
  • Presentation of Financial Results for the Six Months Ended September 30, 2024
  • TSUBURAYA FIELDS HOLDINGS(2767)
  • Fact Book (Supplementary Financial Document for the First Half of the Year Ending March 31, 2025)
  • Financial Presentation for the Six Months Ended September 30, 2024
  • 11/15/2024
  • Ferrotec Holdings(6890)
  • Analyst Report(Shared Research) : Revised FY03/25 forecast; dividends from surplus; increased dividend forecast; share buyback
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • SPACE(9622)
  • Notice of Changes in Officers and Executive Officers and Organizational Changes
  • TMS(4891)
  • TMS Co., Ltd. CEO Takuro Wakabayashi Interviewed on US Internet News Media 'Biotech TV'
  • CTI Engineering(9621)
  • [Updated] Consolidated Financial Results for the Nine Months Ended September 30, 2024
  • TSUBURAYA FIELDS HOLDINGS(2767)
  • Analyst Report(Shared Research) : Business alliance with Daikoku Denki Co., Ltd.
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • Fast Fitness Japan(7092)
  • Analyst Report(Shared Research) : Dividend payment and revision to year-end dividend forecast
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • CUBE(7112)
  • ¡ÎDelayed¡ÏNon-consolidated Financial Results for the Nine Months Ended September 30, 2024(Under Japanese GAAP)
  • TOHO(9602)
  • October 2024 Preliminary Report on Monthly Box Office Revenue (Distributed Dept./Movie Theater Chain)
  • 11/14/2024
  • GLOME Holdings(8938)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • HYOJITO(7368)
  • Non-consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • OMNI-PLUS SYSTEM(7699)
  • Notice on the acquisition of shares (Making a Subsidiary)
  • Notice of interim dividends from retained earnings
  • Consolidated Financial Statements for the 2nd Quarter of the Financial Year Ending March 31, 2025.
  • Estore(4304)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • TSUBURAYA FIELDS HOLDINGS(2767)
  • Notice of Business Alliance with DAIKOKU DENKI Co., Ltd. (Security code: 6430)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024
  • Ferrotec Holdings(6890)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • BPLATS(4381)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • OKADA AIYON(6294)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • BCC(7376)
  • Non-consolidated Financial Results for the Fiscal Year Ended September 30, 2024 (Under Japanese GAAP)
  • YAMAZEN(8051)
  • Revisions to Earnings Forecasts
  • Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on Japanese GAAP)
  • Photosynth(4379)
  • FY2024 3rd Quarter Results Presentation - Q&A (Summary)
  • HOTLAND(3196)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • AZUMA HOUSE(3293)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Digital Information Technologies(3916)
  • Consolidated Financial Results for the Three Months Ended September 30, 2024 (Under Japanese GAAP)
  • Akatsuki Corp(8737)
  • Summary of Business Results for the Second Quarter Ended September 30, 2024 [Japan GAAP] (Consolidated)
  • MELCO HOLDINGS(6676)
  • [Delayed]Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024
  • GREENS(6547)
  • ¡ÌDelayed¡ÍSummary of Consolidated Financial Results for the Three Months Ended September 30, 2024
  • Fast Fitness Japan(7092)
  • Summary of Consolidated Financial Results for the First Six Months ended September 30, 2024 (Japanese GAAP)
  • PCI Holdings(3918)
  • Financial Results for the Fiscal Year Ended September 30, 2024
  • [Summary] Consolidated Financial Results for the Year Ended September 30, 2024
  • Saint Marc Holdings(3395)
  • Monthly Sales Report October 2024
  • Hakudo(7637)
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • NICHIREKI GROUP(5011)
  • [Delayed]Consolidated Financial Results for the Six Months Ended September 30, 2024[Japanese GAAP]
  • [Delayed]Consolidated Financial Results for the Six Months Ended September 30, 2024[Japanese GAAP]
  • eREX(9517)
  • [Delayed]1st Half of Fiscal Year Ending March 31, 2025 Supplementary Materials for Financial Results
  • 11/13/2024
  • Segue Group(3968)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • DELICA FOODS HOLDINGS(3392)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • AKIBA Holdings(6840)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Nihon Seimitsu(7771)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • &Do Holdings(3457)
  • Consolidated Financial Results for the Three Months Ended September 30, 2024 (Under Japanese GAAP)
  • Saint Marc Holdings(3395)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Broad-Minded(7343)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Softfront(2321)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • EPCO(2311)
  • [Delayed]Summary of Consolidated Financial Results for the Nine Months Ended September30,2024(Based on Japanese GAAP)
  • AGP(9377)
  • Supplementary Materials for 2Q of FY2024 (Interim) Financial Results
  • Hakudo(7637)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research): Publication of Phase 1 trial results for sofnobrutinib
  • MELCO HOLDINGS(6676)
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • SBS Holdings(2384)
  • Analyst Report(Shared Research) : Revised FY12/24 earnings forecast
  • Analyst Report(Shared Research) : Released Q3 FY12/24 results
  • Royal Holdings(8179)
  • October 2024 Monthly Sales Report (Same-store sales)
  • NS TOOL(6157)
  • [Delayed]Notice Regarding the Disposal of Treasury Stock as Restricted Stock Compensation
  • Teijin(3401)
  • Teijin Group Integrated Report 2024
  • 11/12/2024
  • Capital Asset Planning(3965)
  • Consolidated Financial Results for the Fiscal Year Ended September 30, 2024 (Under Japanese GAAP)
  • Sansei Landic(3277)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • EPCO(2311)
  • Analyst Report(Shared Research) : Released Q3 FY12/24 results
  • VT HOLDINGS(7593)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on IFRS)
  • TMS(4891)
  • Notice Concerning the Patent for which TMS is granted license (US) to use
  • HAKUTEN(2173)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • TAISEI ONCHO(1904)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • SPACE(9622)
  • Financial Results Briefing Materials for the Nine Months Ended September 30, 2024
  • ¡ÊSummary¡ËConsolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • CTI Engineering(9621)
  • Notice Concerning Share Split and Partial Amendments to the Articles of Incorporation
  • Summary of Financial Results for the third quarter 2024
  • ¡ÚÊä­»ñÎÁ¡Û3Q 62nd Term(2024) Financial Results
  • IMAGICA GROUP(6879)
  • [Delayed]Notice Regarding Revision of Forecast
  • [Delayed]Consolidated Financial Highlights for the Second Quarter of the fiscal year ending March 31, 2025Supplemental Materials
  • The Monogatari Corporation(3097)
  • Notice Regarding October 2024 Preliminary Monthly YoY Change in Sales and Number of Restaurants
  • SWCC(5805)
  • Supplementary Material for the Second Quarter of the Fiscal Year Ending March 2025
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Notice Regarding Recording of Share of Loss of Entities Accounted for Using Equity Method (Non-operating Expenses)
  • Notice Regarding Revisions to Forecasts of Consolidated Financial Results (Upward Revision of Sales and Profits) and Dividend (Dividend Increase) for
  • LECIP HOLDINGS(7213)
  • Summary of Financial Results for the second quarter 2025
  • SBS Holdings(2384)
  • Summary of Business Results for the Third Quarter Ended September 30, 2024 [Japan GAAP] (Consolidated)
  • Notice of Revision to Full-Year Business Forecasts for the Fiscal Year Ending December 2024
  • 11/11/2024
  • Yamaichi Uniheim Real Estate(2984)
  • ¡ÌSummary¡ÍConsolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Royal Holdings(8179)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • HOTLAND(3196)
  • Monthly Sales Report (October)
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research): Released Q3 FY12/24 results
  • HUB(3030)
  • October 2024 Monthly Report
  • TOTECH(9960)
  • TOTECH Group Supplementary Material for Q2 FY3/25
  • ¡ÎSummary¡ÏConsolidated Financial Results for the Six Months Ended September 30, 2024 [Japanese GAAP]
  • CRESCO(4674)
  • Notice Concerning Disposal of Treasury Shares as Restricted Shares Remuneration for Employees of the Company
  • CUBE(7112)
  • [Delayed] [FY12/24] Preliminary Monthly Sales Report of Directly Managed Stores for October 2024
  • Photosynth(4379)
  • FY2024 3Q Results
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 [Japanese GAAP]
  • WATTS(2735)
  • Notice Regarding October 2024 Monthly YoY Change in Sales and Number of Shops
  • Verite(9904)
  • October 2024 Flash Report vs. LY
  • NS TOOL(6157)
  • [Delayed]Summary of Business Results for the Six Months Ended September 30, 2024 [Japan GAAP] (Consolidated)
  • 11/08/2024
  • Open Up Group(2154)
  • Financial Results for Q1 Term Ending June 2025
  • SOLXYZ(4284)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • Global Information(4171)
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • eREX(9517)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under IFRS)
  • JALCO Holdings(6625)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • Carna Biosciences(4572)
  • FY2024 Q3 Presentation
  • Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2024
  • AnGes(4563)
  • Consolidated Financial Report for the Third Quarter 2024
  • CL Holdings(4286)
  • Summary of Financial Results for the third quarter 2024
  • Open Up Group(2154)
  • Consolidated Financial Results for the Three Months Ended September 30, 2024 (Under IFRS)
  • The Monogatari Corporation(3097)
  • Summary of Financial Results for the first quarter 2025
  • Open Up Group(2154)
  • Notice Regarding Credit Rating Acquisition
  • Mcdonald's Holdings(Japan)(2702)
  • 2024 3rd Quarter Earnings Release
  • Overview of Consolidated Financial Results for the Nine Months Ended September 30, 2024
  • Consolidated Financial Results for the Nine Months Ended September 30, 2024
  • TMS(4891)
  • Publication of the Phase 2a Clinical Trial Results of JX10 (TMS-007) in the American Heart Association and American Stroke Association's Stroke
  • ASANTE(6073)
  • October Monthly Sales Report for FY Ending March 2025
  • SEGA SAMMY HOLDINGS(6460)
  • Data Appendix (FY2025/3 Q2)
  • Q2 for the Fiscal Year Ending March 2025 Financial Results Presentation
  • Consolidated Financial Results¡¡for the Six Months Ended September 30, 2024 (Japanese GAAP)
  • ELECOM(6750)
  • ¡ÚDelayed¡ÛConsolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2025
  • 11/07/2024
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research) : Presentation on BTK inhibitor docirbrutinib (AS-1763) at the American Society of Hematology (ASH) annual meeting
  • ALINCO(5933)
  • Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
  • LEADER ELECTRONICS(6867)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • SANKO TECHNO(3435)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024 (Under Japanese GAAP)
  • I-PEX(6640)
  • Summary of Consolidated Financial Results for the Nine Months Ended September 30, 2024 [Japan GAAP]
  • Ad-Sol Nissin(3837)
  • Notice of Revisions of Full-Year Operating Results Forecast
  • Financial Results for Q2 (First Half) FY'25/3
  • Financial Results for the First Half of the Fiscal Year Ending March 31, 2025 (Japanese GAAP, Consolidated)
  • Teijin(3401)
  • Notice regarding Revision of Full Year Earnings Forecasts,Impairment Losses and Extraordinary Loss,Interim Dividend, and Forecast of Dividend
  • Flash Report - Results of FY2024 2Q & Outlook for FY2024 -
  • Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024 [IFRS]
  • SEPTENI HOLDINGS(4293)
  • Notice of Revisions to the Full-Year Consolidated Earnings Estimates for the FY 2024
  • Summary of Consolidated Financial Statement for the Nine Months Ended September 30, 2024 [IFRS]
  • ASANTE(6073)
  • Financial Results for the Second Quarter Ended September 30, 2024
  • AXIS(4012)
  • Non-consolidated Financial Results for the Nine Months Ended September 30, 2024 (Under Japanese GAAP)
  • NICHIREKI GROUP(5011)
  • Nichireki Group Integrated Report 2024
  • 11/06/2024
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research) : International Nonproprietary Name selection for AS-1763
  • Carna announces acceptance of two posters on docirbrutinib (AS-1763) for presentation at ASH Annual Meeting
  • Mcdonald's Holdings(Japan)(2702)
  • Monthly IR News
  • CRESCO(4674)
  • Consolidated Financial Results for the Six Months Ended September 30, 2024
  • ELECOM(6750)
  • Notice of Dividend Payment (Interim Dividend)
  • INTAGE HOLDINGS(4326)
  • Summary of Consolidated Financial Results for the Three Months Ended September 30, 2024 (Japanese GAAP)
  • Supplementary Materials for Consolidated Financial Results for the Three Months Ended September 30, 2024
  • Dream Incubator(4310)
  • Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on Japanese GAAP)
  • 11/05/2024
  • TOP CULTURE(7640)
  • FY10/2024 Preliminary sales figures (October)
  • Carna Biosciences(4572)
  • Carna Announces International Nonproprietary Name Selection for AS-1763
  • Dream Incubator(4310)
  • Analyst Report(Shared Research) : Dividend forecast revision (special dividend)
  • Analyst Report(Shared Research) : Released Q2 FY03/25 results
  • THE PACK(3950)
  • Summary of Financial Results for the third quarter 2024
  • NICHIREKI GROUP(5011)
  • [Delayed]Notice of Dividend Payment from Retained Earnings (Interim Dividend)
  • New Analyst Reports

    12/4 IMAGICA GROUP Inc.(6879) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
    12/4 Infomart Corporation(2492) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/24 [Report Update]
    12/3 AEON DELIGHT CO.,LTD.(9787) Analyst Report(Shared Research) : Achieved the use of renewable energy equivalents at all offices
    11/26 NS TOOL CO.,LTD.(6157) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
    11/25 EPCO Co.,Ltd.(2311) Analyst Report(Shared Research) : Monthly results for October 2024
    11/21 Dream Incubator Inc.(4310) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/25 [Report Update]
    11/14 &Do Holdings Co.,Ltd.(3457) Shared Research Inc. short report on earnings results for the First Quarter of FY06/2025 has been issued
    11/14 Ferrotec Holdings Corporation(6890) Analyst Report(Shared Research) : Revised FY03/25 forecast; dividends from surplus; increased dividend forecast; share buyback
    11/14 TSUBURAYA FIELDS HOLDINGS INC.(2767) Analyst Report(Shared Research) : Business alliance with Daikoku Denki Co., Ltd.
    11/14 Fast Fitness Japan Incorporated(7092) Analyst Report(Shared Research) : Dividend payment and revision to year-end dividend forecast
    11/13 Hakudo Co.,Ltd.(7637) Analyst Report(Shared Research) : Released Q2 FY03/25 results
    11/13 Carna Biosciences, Inc.(4572) Analyst Report(Shared Research): Publication of Phase 1 trial results for sofnobrutinib
    11/12 MELCO HOLDINGS INC.(6676) Analyst Report(Shared Research) : Released Q2 FY03/25 results
    11/12 SBS Holdings,Inc(2384) Analyst Report(Shared Research) : Revised FY12/24 earnings forecast

    Latest Video & Presentations

    Latest Video&Slides

    Company news
    provided by Timely Disclosure Network

    News Release

    Stock Code or Name:

    4506   Dainippon Sumitomo Pharma Co.,Ltd.

    10/30/2024 13:30 Sumitomo Pharma Announces the Results of Its Early Retirement Program Offer to Employees in Japan for Business Structural Reform
    10/30/2024 13:30 Notice Concerning Finance Costs
    10/30/2024 13:30 Conference on Q2 FY2024 (April 1, 2024 to September 30, 2024) Financial Results
    10/30/2024 13:30 Supplementary Financial Data (IFRS) for the Second Quarter of the Year Ending March 31, 2025
    10/30/2024 13:30 Summary of Consolidated Financial Results for the Second Quarter (First Half) of the Year Ending March 31, 2025 [IFRS]
    07/31/2024 15:30 Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2025 [IFRS]
    07/31/2024 15:30 Conference on Q1 FY2024 (April 1, 2024 to June 30, 2024) Financial Results
    07/31/2024 15:30 Sumitomo Pharma Announces Offering an Early Retirement Program to Employees in Japan for Business Structural Reform
    07/31/2024 15:30 Notice Concerning Finance Income
    07/31/2024 15:30 Supplementary Financial Data (IFRS) for the First Quarter of the Year Ending March 31, 2025
    07/01/2024 10:00 Corporate Governance Report
    05/14/2024 13:00 Sumitomo Pharma Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Director and Executive Officer.
    05/14/2024 13:00 Sumitomo Pharma Announces Reduction in Executive Remuneration
    05/14/2024 13:00 Conference on FY2023 (April 1,2023 to March 31, 2024) Financial Results
    05/14/2024 13:00 Summary of Consolidated Financial Results for the Year Ended March 31, 2024 [IFRS]
    05/14/2024 13:00 Supplementary Financial Data (IFRS) for the Year Ended March 31, 2024
    05/09/2024 19:30 Notice of Company Split of the Frontier Business and Notice of Business Acquisition by a Wholly-Owned Subsidiary of the Company
    04/30/2024 08:45 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024
    04/30/2024 08:30 Sumitomo Pharma Announces Its Financial Forecasts Revision for FY2023, Financial and Dividend Forecasts for FY2024
    04/30/2024 08:30 Notice Concerning Impairment Losses, Business Structure Improvement Expenses, and Finance Income
    04/02/2024 20:00 Sumitomo Pharma Announces Sale of Strategic Shareholdings
    03/15/2024 15:30 Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License for Four Compounds Including Ulotaront with Otsuka
    03/04/2024 22:00 Sumitomo Pharma Announces Reduction of Workforce and Other Rationalization Measures of the USA Consolidated Subsidiary
    01/31/2024 15:30 Sumitomo Pharma Announces Revisions to Its Financial Forecasts
    01/31/2024 15:30 Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2024 [IFRS]
    01/31/2024 15:30 Conference on Q3 FY2023 (April 1 to December 31, 2023) Financial Results
    01/31/2024 15:30 Supplementary Financial Data (IFRS) for the Third Quarter of the Year Ending March 31, 2024
    01/31/2024 15:30 Notice Concerning Finance Income
    01/31/2024 15:30 Posting of Business Structure Improvement Expenses
    Scroll Image
    ¥¹¥¯¥í¡¼¥ë²èÁü